A detailed history of Massmutual Trust CO Fsb transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 1,842 shares of CRL stock, worth $360,608. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,842
Previous 1,763 4.48%
Holding current value
$360,608
Previous $364,000 0.55%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$187.96 - $245.29 $14,848 - $19,377
79 Added 4.48%
1,842 $362,000
Q2 2024

Jul 02, 2024

BUY
$206.39 - $268.73 $316,189 - $411,694
1,532 Added 663.2%
1,763 $364,000
Q1 2024

Apr 09, 2024

SELL
$203.52 - $273.43 $19,741 - $26,522
-97 Reduced 29.57%
231 $62,000
Q4 2023

Jan 03, 2024

BUY
$164.52 - $238.84 $9,542 - $13,852
58 Added 21.48%
328 $77,000
Q3 2023

Oct 03, 2023

BUY
$194.44 - $217.61 $10,110 - $11,315
52 Added 23.85%
270 $52,000
Q2 2023

Aug 01, 2023

BUY
$183.71 - $210.25 $13,043 - $14,927
71 Added 48.3%
218 $45,000
Q1 2023

Apr 11, 2023

BUY
$191.89 - $259.92 $191 - $259
1 Added 0.68%
147 $29,000
Q4 2022

Jan 06, 2023

BUY
$197.11 - $250.07 $2,365 - $3,000
12 Added 8.96%
146 $32,000
Q3 2022

Oct 07, 2022

SELL
$182.44 - $250.54 $1,277 - $1,753
-7 Reduced 4.96%
134 $26,000
Q2 2022

Jul 07, 2022

BUY
$204.13 - $302.4 $2,857 - $4,233
14 Added 11.02%
141 $30,000
Q1 2022

Apr 08, 2022

SELL
$255.51 - $362.11 $1,533 - $2,172
-6 Reduced 4.51%
127 $36,000
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $4,471 - $5,499
-12 Reduced 8.28%
133 $55,000
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $32,358 - $40,881
110 Added 314.29%
145 $54,000
Q1 2021

May 17, 2021

BUY
$249.67 - $299.48 $8,738 - $10,481
35 New
35 $10,000
Q1 2020

May 15, 2020

SELL
$98.9 - $178.34 $8,999 - $16,228
-91 Closed
0 $0
Q4 2019

May 15, 2020

SELL
$126.05 - $152.76 $4,285 - $5,193
-34 Reduced 27.2%
91 $14,000
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $524 - $733
-5 Reduced 3.85%
125 $18.2 Million
Q4 2018

Feb 26, 2019

SELL
$105.09 - $137.23 $3,047 - $3,979
-29 Reduced 18.24%
130 $14.7 Million
Q3 2018

Nov 09, 2018

SELL
$112.11 - $134.54 $361,218 - $433,487
-3,222 Reduced 95.3%
159 $21.4 Million
Q2 2018

Aug 20, 2018

BUY
$102.37 - $117.25 $18,733 - $21,456
183 Added 5.72%
3,381 $380 Million
Q1 2018

May 21, 2018

BUY
$98.19 - $115.2 $30,340 - $35,596
309 Added 10.7%
3,198 $341 Million
Q4 2017

Mar 01, 2018

BUY
$100.43 - $118.09 $288,234 - $338,918
2,870 Added 15105.26%
2,889 $316 Million
Q4 2017

Feb 21, 2018

SELL
$100.43 - $118.09 $281,706 - $331,242
-2,805 Reduced 99.33%
19 $546,000
Q3 2017

Feb 13, 2018

BUY
$96.72 - $109.26 $12,670 - $14,313
131 Added 4.86%
2,824 $305 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,693
2,693 $272 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.